Skip to main content
Equibles

Allianz Asset Management GmbH

Position in MRK — Merck & Co., Inc.

CIK 1535323 MUNICH, 2M
Back to MRK Full portfolio

Position in MRK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$477,164,575
+$227,960 QoQ
Shares Held
3,713,343
-6.3% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#70
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 68% Shared 0% None 32%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Derivatives in MRK

reported options exposure · as of Jun 30, 2026
CallValue
$19,570,550
CallShares
152,300
PutValue
$25,532,950
PutShares
198,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Allianz Asset Management GmbH holds $5,256,144,156 across 13 Drug Manufacturers - General names. MRK ranks #4 (9.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AZN
Astrazeneca PLC
 6,830,190 $1,295,140,626
2 JNJ
Johnson & Johnson
 4,873,739 $1,237,783,491
3 LLY
ELI LILLY & Co
 477,197 $572,364,441
4 MRK
Merck & Co., Inc.
This page 		3,713,343 $477,164,575
5 BMY
Bristol Myers Squibb Co
 8,275,402 $476,828,662
6 ABBV
AbbVie Inc.
 1,566,077 $394,087,615
7 GILD
Gilead Sciences, Inc.
 2,853,184 $360,471,266
8 AMGN
Amgen Inc
 636,542 $230,504,586

All Filings in MRK

Export CSV
46 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,570,550 152,300
2026-06-30 $477,164,575 3,713,343
2026-06-30 $25,532,950 198,700
2026-03-31 $20,750,025 172,500
2026-03-31 $13,340,161 110,900
2026-03-31 $476,936,615 3,964,890
2025-12-31 $417,548,103 3,966,826
2025-12-31 $11,894,380 113,000
2025-12-31 $17,125,802 162,700
2025-09-30 $271,340,485 3,232,938
2025-09-30 $9,752,666 116,200
2025-09-30 $13,680,590 163,000
2025-06-30 $15,800,336 199,600
2025-06-30 $164,904,131 2,083,175
2025-06-30 $10,504,532 132,700
2025-03-31 $11,767,536 131,100
2025-03-31 $169,734,004 1,890,976
2025-03-31 $16,444,032 183,200
2024-12-31 $162,598,864 1,634,488
2024-12-31 $6,177,708 62,100
2024-12-31 $10,813,476 108,700
2024-09-30 $203,300,675 1,790,249
2024-09-30 $9,959,212 87,700
2024-09-30 $14,070,084 123,900
2024-06-30 $8,356,500 67,500
2024-06-30 $6,338,560 51,200
2024-06-30 $287,822,989 2,324,903
2024-03-31 $540,995 4,100
2024-03-31 $329,281,090 2,495,499
2024-03-31 $316,680 2,400
2023-12-31 $350,426,688 3,214,334
2023-09-30 $394,053,682 3,827,622
2023-06-30 $502,148,660 4,351,752
2023-03-31 $537,168,960 5,049,055
2022-12-31 $545,677,061 4,918,225
2022-09-30 $468,761,492 5,443,120
2022-06-30 $541,769,974 5,942,415
2022-03-31 $431,110,799 5,254,245
2021-12-31 $315,068,418 4,111,018
2021-09-30 $310,964,335 4,140,119
2021-06-30 $248,488,369 3,195,170
2021-03-31 $232,587,669 3,017,091
2020-12-31 $425,470,809 5,201,357
2020-09-30 $373,392,379 4,501,413
2020-06-30 $396,202,976 5,123,533
2020-03-31 $428,598,936 5,570,563

Report a Problem

Category
Description
Email (optional, for follow-up)